Cargando…
Pancreas Cancer‐Associated Pain Management
Pain is highly prevalent in patients with pancreas cancer and contributes to the morbidity of the disease. Pain may be due to pancreatic enzyme insufficiency, obstruction, and/or a direct mass effect on nerves in the celiac plexus. Proper supportive care to decrease pain is an important aspect of th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176967/ https://www.ncbi.nlm.nih.gov/pubmed/33885205 http://dx.doi.org/10.1002/onco.13796 |
_version_ | 1783703336898265088 |
---|---|
author | Coveler, Andrew L. Mizrahi, Jonathan Eastman, Bory Apisarnthanarax, Smith “Jim” Dalal, Shalini McNearney, Terry Pant, Shubham |
author_facet | Coveler, Andrew L. Mizrahi, Jonathan Eastman, Bory Apisarnthanarax, Smith “Jim” Dalal, Shalini McNearney, Terry Pant, Shubham |
author_sort | Coveler, Andrew L. |
collection | PubMed |
description | Pain is highly prevalent in patients with pancreas cancer and contributes to the morbidity of the disease. Pain may be due to pancreatic enzyme insufficiency, obstruction, and/or a direct mass effect on nerves in the celiac plexus. Proper supportive care to decrease pain is an important aspect of the overall management of these patients. There are limited data specific to the management of pain caused by pancreatic cancer. Here we review the literature and offer recommendations regarding multiple modalities available to treat pain in these patients. The dissemination and adoption of these best supportive care practices can improve quantity and quality of life for patients with pancreatic cancer. IMPLICATIONS FOR PRACTICE: Pain management is important to improve the quality of life and survival of a patient with cancer. The pathophysiology of pain in pancreas cancer is complex and multifactorial. Despite tumor response to chemotherapy, a sizeable percentage of patients are at risk for ongoing cancer‐related pain and its comorbid consequences. Accordingly, the management of pain in patients with pancreas cancer can be challenging and often requires a multifaceted approach. |
format | Online Article Text |
id | pubmed-8176967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81769672021-06-15 Pancreas Cancer‐Associated Pain Management Coveler, Andrew L. Mizrahi, Jonathan Eastman, Bory Apisarnthanarax, Smith “Jim” Dalal, Shalini McNearney, Terry Pant, Shubham Oncologist Gastrointestinal Cancer Pain is highly prevalent in patients with pancreas cancer and contributes to the morbidity of the disease. Pain may be due to pancreatic enzyme insufficiency, obstruction, and/or a direct mass effect on nerves in the celiac plexus. Proper supportive care to decrease pain is an important aspect of the overall management of these patients. There are limited data specific to the management of pain caused by pancreatic cancer. Here we review the literature and offer recommendations regarding multiple modalities available to treat pain in these patients. The dissemination and adoption of these best supportive care practices can improve quantity and quality of life for patients with pancreatic cancer. IMPLICATIONS FOR PRACTICE: Pain management is important to improve the quality of life and survival of a patient with cancer. The pathophysiology of pain in pancreas cancer is complex and multifactorial. Despite tumor response to chemotherapy, a sizeable percentage of patients are at risk for ongoing cancer‐related pain and its comorbid consequences. Accordingly, the management of pain in patients with pancreas cancer can be challenging and often requires a multifaceted approach. John Wiley & Sons, Inc. 2021-05-12 2021-06 /pmc/articles/PMC8176967/ /pubmed/33885205 http://dx.doi.org/10.1002/onco.13796 Text en © 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Gastrointestinal Cancer Coveler, Andrew L. Mizrahi, Jonathan Eastman, Bory Apisarnthanarax, Smith “Jim” Dalal, Shalini McNearney, Terry Pant, Shubham Pancreas Cancer‐Associated Pain Management |
title | Pancreas Cancer‐Associated Pain Management |
title_full | Pancreas Cancer‐Associated Pain Management |
title_fullStr | Pancreas Cancer‐Associated Pain Management |
title_full_unstemmed | Pancreas Cancer‐Associated Pain Management |
title_short | Pancreas Cancer‐Associated Pain Management |
title_sort | pancreas cancer‐associated pain management |
topic | Gastrointestinal Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176967/ https://www.ncbi.nlm.nih.gov/pubmed/33885205 http://dx.doi.org/10.1002/onco.13796 |
work_keys_str_mv | AT covelerandrewl pancreascancerassociatedpainmanagement AT mizrahijonathan pancreascancerassociatedpainmanagement AT eastmanbory pancreascancerassociatedpainmanagement AT apisarnthanaraxsmithjim pancreascancerassociatedpainmanagement AT dalalshalini pancreascancerassociatedpainmanagement AT mcnearneyterry pancreascancerassociatedpainmanagement AT pantshubham pancreascancerassociatedpainmanagement AT pancreascancerassociatedpainmanagement |